<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="15354">Choline</z:chebi> acetyltransferase activity (presynaptic cholinergic system) and high affinity binding of <z:chebi fb="0" ids="48873">cholinergic antagonists</z:chebi> (postsynaptic cholinergic system) were measured in brain tissue removed after <z:hpo ids='HP_0011420'>death</z:hpo> from both mentally <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> old people </plain></SENT>
<SENT sid="1" pm="."><plain>Muscarinic receptor binding sites in frontal cortex decreased with advancing years only in old people without appreciable morphological evidence of senile degeration </plain></SENT>
<SENT sid="2" pm="."><plain>Preliminary data for temporal lobe suggested that also in <z:e sem="disease" ids="C0236642" disease_type="Disease or Syndrome" abbrv="">Pick's disease</z:e> the density of receptor binding sites is reduced </plain></SENT>
<SENT sid="3" pm="."><plain>The markers are not significantly reduced in cases of mixed senile and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, in non-vascular senile <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type, there were indications that the presynaptic marker is selectively depleted </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, centrally acting anticholinesterases might be beneficial, particularly in the early stages of the disease </plain></SENT>
</text></document>